Our broad-based transaction experience extends across a range of situations, industries and enterprise values
Categories
Year
Type
Industry
Announced: February 19, 2024Value: $35.3 billionStatus: PendingExclusive financial advisor to Capital One on its acquisition of Discover
Announced: April 2, 2024Value: $25 billionStatus: PendingExclusive financial advisor to the Special Committee of Endeavor on its sale to Silver Lake
Announced: April 2, 2024Value: $8.2 billionStatus: PendingExclusive financial advisor to ChampionX on its sale to SLB
Announced: June 3, 2024Value: $7.2 billionStatus: PendingExclusive financial advisor to Waste Management on its acquisition of Stericycle
Announced: May 13, 2024Value: $6.9 billionStatus: PendingExclusive financial advisor to the Special Committee of Squarespace’s Board of Directors
Announced: June 7, 2024Value: $5.6 billionStatus: PendingExclusive financial advisor to the Special Committee of the PowerSchool Board of Directors
Announced: April 10, 2024Value: $4.95 billionStatus: PendingExclusive financial advisor to Alpine on its sale to Vertex
Announced: May 28, 2024Value: $4.4 billionStatus: PendingFinancial advisor to TDS (controlling shareholder of UScellular) on the sale of UScellular's wireless operations and select spectrum assets to T-Mobile
Announced: February 12, 2024Value: $4.3 billionStatus: PendingLead financial advisor to CymaBay on its sale to Gilead
Announced: January 31, 2024Value: $3.7 billionStatus: PendingLead financial advisor to Cigna on the sale of its Medicare Businesses and CareAllies to HCSC
Announced: February 5, 2024Value: €2.7 billionStatus: PendingExclusive financial advisor to MorphoSys on its sale to Novartis
Announced: July 8, 2024Value: $3.2 billionStatus: PendingExclusive financial advisor to Morphic in its sale to Eli Lilly
Announced: May 29, 2024Value: Up to $3 billionStatus: PendingExclusive financial advisor to Eyebio on its sale to Merck
Announced: April 22, 2024Value: $2.9 billionStatus: PendingExclusive financial advisor to C&S on its acquisition of 579 stores and various facilities that have become available from the Kroger and Albertsons merger
Announced: February 26, 2024Value: $2.5 billionStatus: PendingExclusive financial advisor to the Special Committee of Agiliti on its sale to THL Partners
Announced: March 19, 2024Value: Up to $2.4 billionStatus: ClosedExclusive financial advisor to Fusion on its sale to AstraZeneca
Announced: January 22, 2024Value: Up to $2.2 billionStatus: ClosedExclusive financial advisor to Inhibrx on its sale to Sanofi and pro rata distribution of shares in a new publicly traded biopharma company
Announced: January 8, 2024Value: $2 billionStatus: PendingLead financial advisor to Ambrx on its sale to Johnson & Johnson
Announced: May 2, 2024Value: $1.75 billionStatus: ClosedFinancial advisor to Mariana on its sale to Novartis
Announced: February 16, 2024Value: $1.65 billionStatus: PendingExclusive financial advisor to the Special Committee of HireRight on its sale to General Atlantic and Stone Point
Announced: March 28, 2024Value: $1.5 billionStatus: PendingJoint-lead financial adviser to Keysight on its acquisition of Spirent Communications
Announced: March 25, 2024Value: Up to €1.025 billionStatus: PendingExclusive financial advisor to Cardior on its sale to Novo Nordisk
Announced: May 28, 2024Value: $1.25 billionStatus: PendingLead financial advisor to Numab Therapeutics on its sale of NM-26, a bi-specific antibody, to Johnson & Johnson
Announced: March 14, 2024Value: Up to $1.05 billionStatus: PendingLead financial advisor to Amolyt Pharma on its sale to AstraZeneca
Announced: April 23, 2024Value: $750 millionStatus: ClosedFinancial advisor to Escient Pharmaceuticals on its sale to Incyte Corporation
Announced: January 8, 2024Value: $680 millionStatus: PendingExclusive financial advisor to Harpoon on its sale to Merck
Announced: April 7, 2024Value: $640 millionStatus: PendingFinancial advisor to Kimberly-Clark on the sale of its Personal Protective Equipment business to Ansell
Announced: June 24, 2024Value: Up to $435 millionStatus: PendingLead financial advisor to Alimera in its sale to ANI Pharmaceuticals
Announced: March 12, 2024Value: €275 millionStatus: ClosedExclusive financial advisor to Accor on its share repurchase from Jinjiang International
Announced: April 29, 2024Value: $280 millionStatus: PendingExclusive financial advisor to Simply Good Foods on its acquisition of Only What You Need (OWYN)
Announced: February 29, 2024Value: $78.6 millionStatus: ClosedExclusive financing advisor to The Children's Place on its financing agreement with Mithaq Capital
Announced: June 6, 2024Status: PendingExclusive financial advisor to PharmaCord on its sale to Permira
Announced: June 5, 2024Status: PendingExclusive financial advisor to Advent International on its strategic investment in Prometheus Group
Announced: June 4, 2024Status: ClosedFinancial advisor to CapVest on its partial equity recapitalization of Datasite LLC
Announced: June 3, 2024Status: PendingFinancial advisor to Illumina on its spin-off of GRAIL
Announced: May 22, 2024Status: PendingFinancial advisor to DuPont on its separation into three independent, publicly-traded companies
Announced: May 16, 2024Status: PendingExclusive financial advisor to Proteologix on its sale to Johnson & Johnson
Announced: May 3, 2024Status: PendingFinancial advisor to Uniti on its merger with Windstream
Announced: April 23, 2024Status: ClosedExclusive financial advisor to IANS on its strategic investment from Apax Digital
Announced: April 22, 2024Status: PendingExclusive financial advisor to Nexus on the sale of an injectable medicine manufacturing facility to Eli Lilly
Announced: April 19, 2024Status: ClosedExclusive financial advisor to EyeCare Partners on its private debt exchange and new money investment
Announced: April 10, 2024Status: ClosedExclusive financial advisor to eBay in its acquisition of Goldin from Collectors, sale of eBay Vault to PSA and commercial agreement with Collectors
Announced: April 3, 2024Status: ClosedAdvisor to Disney in connection with its proxy contest with Trian Partners and Blackwells, as well as its settlement with ValueAct
Announced: March 11, 2024Exclusive financial advisor to Advance Auto Parts on the announcement of a cooperation agreement with Third Point and Saddle Point
Announced: March 4, 2024Status: ClosedFinancial advisor to Ventas on the announcement of a cooperation agreement with Land & Buildings
Announced: February 26, 2024Status: PendingFinancial advisor to Avison Young on its recapitalization transaction and new capital investment
Announced: February 14, 2024Status: PendingExclusive financial advisor to Delphix on its sale to Perforce
Announced: February 13, 2024Status: PendingExclusive financial advisor to the Special Committee of REV Group regarding its secondary offering and share repurchase of American Industrial Partners' ownership stake
Announced: January 30, 2024Status: ClosedExclusive financial advisor to Dave on its repurchase of a convertible note from FTX
Announced: January 19, 2024Status: ClosedExclusive financial advisor to an ad-hoc group of crossover creditors on Radiology Partners' set of refinancing transactions
Announced: January 17, 2024Status: PendingExclusive financial advisor to the ad-hoc group of first lien creditors on Diamond Sports Group's Restructuring Support Agreement and investment from Amazon
Announced: January 11, 2024Status: ClosedExclusive financial advisor to Wolverine on the sale of Sperry to Authentic Brands and ALDO
Announced: January 10, 2024Status: PendingFinancial advisor to Informa on the combination of Informa Tech's digital businesses with TechTarget
Announced: January 9, 2024Status: PendingFinancial advisor to Wiley on the divestiture of its Wiley Edge business to Inspirit Capital
Announced: January 2, 2024Status: PendingExclusive financial advisor to Danone on the sale of a majority stake in its U.S. premium organic dairy business to Platinum Equity